Altavant Sciences

Mar 02, 2020

Altavant Sciences Appoints Respiratory Disease Medical Expert as Chief Medical Officer

Oct 22, 2019

Altavant Sciences Presents Data at CHEST 2019 Supporting Once-Daily Dosing of Rodatristat Ethyl for the Treatment of Pulmonary Arterial Hypertension

Oct 18, 2019

Altavant Sciences to Present Data Supporting Once-Daily Dosing of Rodatristat Ethyl at CHEST 2019

Oct 01, 2019

Altavant Sciences Presents Data at ERS International Congress 2019 Demonstrating Strong Safety and Tolerability Profile of Rodatristat Ethyl

Sep 24, 2019

Altavant Sciences to Present New Rodatristat Ethyl Clinical Biomarker and Safety Findings at the ERS International Congress 2019

Sep 05, 2019

Altavant Sciences Presents Patient-Centric Approach to Drug Development at PHA's Annual PHPN Symposium

Aug 05, 2019

Altavant Sciences Initiates Phase 2a Study of Rodatristat Ethyl in Pulmonary Arterial Hypertension

May 09, 2019

Altavant Sciences to Provide Corporate and Clinical Update at 2019 Respiratory Innovation Summit

Jan 02, 2019

Altavant Sciences Appoints Lyn Baranowski Chief Operating Officer